How do we fuel the rise of the scientist-CEO? 🚀
Glad you asked... @BryReinhardt and I just published this piece in @GENBiotechJrnl https://t.co/XHcR8G5HpK
Comment your fave WTF biotech VC moment. I'll start:
Having to explain the difference between GLP & GMP to the Managing Partner of an IND-stage focused fund 🙈
Can't believe it's already been a year that I've been writing the "VC Corner" for The House Brazeryen, @BrazenBio's bi-weekly newsletter! I also can't believe I didn't even realize that yesterday was a year 🤦♂️
"Building a therapeutics startup ✨WITHOUT✨ VC?!!?!"
Read all about that, Venture Fellows, the lack of diversity in VC funding, AND MORE in the latest issue of Brazen Bio's newsletter: The House Brazeryen 🐉
https://t.co/7bBVIg6Gnr
@BrazenCapital@bigaxon#biotech#startup
Biotech VC is broken. I raised $20M in funding and developed my therapeutic idea into a clinical stage drug ONE ANGEL INVESTOR CHECK AT A TIME (no VC). 💪🏽
Patients are waiting. Which biotech investors will join the #scientistCEO movement?
@BrazenBio@BrazenCapital#BeBrazen
You don’t need venture capital to develop a therapeutic 💉💊
.
You can do it a million dollars at a time (we need more investors to understand this). #biotech#startup